Impact of NCD guidelines on Medicare patients with chemotherapy-induced anemia receiving erythropoiesis-stimulating agents: results from a community oncology practice-Reference-Cited by-同舟云学术

Impact of NCD guidelines on Medicare patients with chemotherapy-induced anemia receiving erythropoiesis-stimulating agents: results from a community oncology practice

Published:2009-06 Issue:6 Volume:6 Page:257-261
ISSN:1548-5315
Container-title:Community Oncology
language:en
Short-container-title:Community Oncology

Author:

Feinberg Bruce,Gilmore James,Gondesen Tom,Jackson James H.,Saleh Mansoor

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference21 articles.

1. Chemotherapy-induced anemia in adults: incidence and treatment;Groopman;J Natl Cancer Inst,1999

2. Epidemiology of anemia in the elderly: information on diagnostic evaluation;Balducci;J Am Geriatr Soc,2003

3. Chemotherapy-induced anemia in adults: incidence and treatment [published erratum];Groopman;J Natl Cancer Inst,2000

4. Reductions in anaemia and fatigue are associated with improvements in productivity in cancer patients receiving chemotherapy;Berndt;Pharmacoeconomics,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in anemia treatment among patients with five non-myeloid malignancies treated with chemotherapy in a large integrated health care delivery system in California, 2000–2013;Supportive Care in Cancer;2016-02-12

2. Blood utilization and hemoglobin levels in cancer patients after label and coverage changes for erythropoiesis-stimulating agents;Expert Review of Hematology;2014-08

3. Propensity score matched assessment of treatment patterns and cost of erythropoiesis stimulating agent treatment in patients with cancer receiving myelosuppressive chemotherapy;Journal of Oncology Pharmacy Practice;2012-12-12

4. Hemoglobin decline in cancer patients receiving chemotherapy without an erythropoiesis-stimulating agent;Supportive Care in Cancer;2012-10-25

5. Impact of Centers for Medicare & Medicaid Services national coverage determination on erythropoiesis-stimulating agent and transfusion use in chemotherapy-treated cancer patients;Pharmacoepidemiology and Drug Safety;2012-03-26